He's at it again. Good old David Stanton, whom I hold in little regard, once again comes out with another analyst report for cuv.
What's hilarious about this: His post share consolidation target price of $8.20 is less than his previous target prices when you factor in the share consolidation (0.82 without the 10:1).
This guy consisently lowers his target price about .05 (not factoring in the consolidation) and he's been lowering it for years. He HAS NEVER even come close to having one of his target prices hit. Just look at his previous analyst reports. That will prove it.
What is also sick about this is that under the old Epitan, Intersuisse came out with an analyst report back in 2004 that had Epitan at a price target of around $8 by now (from <$1 pps to $8 pps).
Now Clinuvel mgmnt finally gets their own $8 price target from an analyst...but only after they do a 10:1 consolidation!
The spread on CLVLY is now ridiculous - A bid of $2.17, with an ask of $2.80.
Gee, thanks for making the ADR more attractive, guys. Spreads like that chase many investors away.
Should have gone for a 100:1 consolidation. Then you could brag it's a $10 stock.
As for Stanton, how about a new line of work? Can't believe someone is paying you for your services, quite frankly.
CUV Price at posting:
$1.70 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)